Eli Lilly pharmaceutical provides for 20 in the next releases do 10 years

U.s. pharmaceutical Eli Lilly reported on Tuesday, in an event for investors, which has the potential to launch 20 new medicines and treatments in the next ten years. The releases are concentrated in five areas: diabetes, Oncology, immunology, Neurodegeneration and chronic pain.
"We are happy to share with investors the breadth and depth of Lilly''s portfolio that shows our progress in major therapeutic areas. The portfolio ranges from recent releases to a strong asset tracking in advanced stage or in regulatory review, "said John c. Leichleiter, President of pharmaceuticals.